IS THE COMBINED TARGET TIME IN RANGE/TIME BELOW RANGE ACHIEVABLE? EVALUATION OF GLYCEMIC PARAMETERS IN TYPE I DIABETES USERS OF FLASH CONTINUOUS GLUCOSE MONITORING SYSTEM

被引：0
|
作者：
Rovira, G. [1 ]
Avila, T. [2 ]
机构：
[1] British Hosp, Endocrinol, Buenos Aires, DF, Argentina
[2] British Hosp, Nutr, Buenos Aires, DF, Argentina
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
749
引用
下载
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [1] Significance of "Time below Range" as a Glycemic Marker Derived from Continuous Glucose Monitoring in Japanese Children and Adolescents with Type 1 Diabetes
    Urakami, Tatsuhiko
    Yoshida, Kei
    Kuwabara, Remi
    Mine, Yusuke
    Aoki, Masako
    Suzuki, Junichi
    Morioka, Ichiro
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 (04): : 251 - 257
  • [2] Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes
    Thomas, Robert L.
    Boeder, Schafer C.
    Hamidi, Vala
    Giovannetti, Erin R.
    Gregory, Justin M.
    Pettus, Jeremy H.
    DIABETES CARE, 2024, 47 (05) : e39 - e41
  • [3] Perinatal outcomes and time-in-range on continuous glucose monitoring for type 1 diabetes
    Sobhani, Nasim C.
    Goemans, Sophie L.
    Nguyen, Antoinette
    Richley, Michael
    Gabby, Lauryn
    Han, Christina S.
    Ramos, Gladys A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S72 - S73
  • [4] Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
    Yoo, Jee Hee
    Kim, Jae Hyeon
    DIABETES & METABOLISM JOURNAL, 2020, 44 (06) : 828 - 839
  • [5] Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM)
    Yayu Fang
    Wei Liu
    Xiaoling Cai
    Yu Zhu
    Mingxia Zhang
    Siqian Gong
    Xiangqing Wang
    Chu Lin
    Rui Zhang
    Sai Yin
    Juan Li
    Yongran Huo
    Xiaodan Hu
    Xiaoqi Xie
    Linong Ji
    Diabetology & Metabolic Syndrome, 17 (1):
  • [6] The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring
    Diaz-Soto, Gonzalo
    Bahillo-Curieses, M. Pilar
    Jimenez, Rebeca
    Nietoa, Maria de la.
    Gomez, Emilia
    Torres, Beatriz
    Lopez Gomez, Juan Jose
    de Luis, Daniel
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (07): : 465 - 471
  • [7] Satisfaction with continuous glucose monitoring is positively correlated with time in range in children with type 1 diabetes
    Marigliano, Marco
    Pertile, Riccardo
    Mozzillo, Enza
    Troncone, Alda
    Maffeis, Claudio
    Morotti, Elisa
    Di Candia, Francesca
    Fedi, Ludovica
    Iafusco, Dario
    Zanfardino, Angela
    Cauvin, Vittoria
    Maltoni, Giulio
    Zucchini, Stefano
    Cherubini, Valentino
    Tiberi, Valentina
    Minuto, Nicola
    Bassi, Marta
    Rabbone, Ivana
    Savastio, Silvia
    Tinti, Davide
    Tornese, Gianluca
    Schiaffini, Riccardo
    Passanisi, Stefano
    Lombardo, Fortunato
    Bonfanti, Riccardo
    Scaramuzza, Andrea
    Franceschi, Roberto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 204
  • [8] Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
    Lu, Jingyi
    Ma, Xiaojing
    Zhou, Jian
    Zhang, Lei
    Mo, Yifei
    Ying, Lingwen
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Vigersky, Robert A.
    Jia, Weiping
    DIABETES CARE, 2018, 41 (11) : 2370 - 2376
  • [9] ASSOCIATION BETWEEN CONTINUOUS GLUCOSE MONITORING DERIVED TIME IN RANGE AND MICROALBUMINURIA IN TYPE 2 DIABETES
    Yoo, J. H.
    Kim, G.
    Sim, K. H.
    Jin, S. -M.
    Lee, H. J.
    Hwang, Y. -C.
    Kim, J. H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A220 - A220
  • [10] INSIGHTS TO THE TIME IN RANGE (TIR) IN PATIENTS ON FLASH GLUCOSE MONITORING (FGM) IN PATIENTS WITH TYPE 2 DIABETES
    Chawla, M.
    Chawla, P.
    Saboo, B.
    Kesavadev, J.
    Shah, A.
    Krishnan, G.
    Shah, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A123 - A124
12345